AJOVY
Live / Registered — Registered — Sections 8 & 15 accepted and acknowledged (as of 03 Apr 2025)
What this means for you
Registered since 18 Dec 2018. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 18 Dec 2028: the §8 & §9 renewal).
Record
- Serial number
- 87237174
- Registration number
- 5633449
- Mark type
- Word mark
- Filed
- 15 Nov 2016
- Published for opposition
- 04 Apr 2017
- Registered
- 18 Dec 2018
- Next maintenance filing
- §8 & §9 renewal, due by 18 Dec 2028 (grace period to 18 Jun 2029)
- Attorney of record
- Lori Wolfe
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment of migraines
Owner
- TEVA PHARMACEUTICALS INTERNATIONAL GMBH, JONA, CH
- Teva Pharmaceutical Industries Limited, Jerusalem, IL
- Teva Pharmaceutical Industries Limited, Jerusalem, IL
- Teva Pharmaceutical Industries Limited, Jerusalem, IL
Prosecution history
- 18 Feb 2026 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 18 Feb 2026 — TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
- 18 Feb 2026 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 18 Feb 2026 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 03 Apr 2025 — NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
- 03 Apr 2025 — REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
- 03 Apr 2025 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 18 Dec 2024 — TEAS SECTION 8 & 15 RECEIVED
- 18 Dec 2023 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 16 Dec 2020 — AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
- 18 Dec 2018 — REGISTERED-PRINCIPAL REGISTER
- 14 Nov 2018 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 13 Nov 2018 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 25 Oct 2018 — STATEMENT OF USE PROCESSING COMPLETE
- 27 Sept 2018 — USE AMENDMENT FILED